Epirubicin companion diagnostic - Medical Prognosis Institute

Drug Profile

Epirubicin companion diagnostic - Medical Prognosis Institute

Alternative Names: Epirubicin DRP

Latest Information Update: 02 Jun 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Medical Prognosis Institute
  • Class Diagnostic agents
  • Mechanism of Action Undefined mechanism
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Clinical Phase Unknown Breast cancer

Most Recent Events

  • 17 May 2017 Clinical trials in Breast cancer (Diagnosis) in Denmark (unspecified route)
  • 17 May 2017 Efficacy data from a clinical trial in Breast cancer released by Medical Prognosis Institute
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top